Stockreport

Longeveron Announces Closing of $5.2 Million Public Offering

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF MIAMI, April 11, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular th [Read more]